Anti-Loricrin antibody [EPR7148(2)(B)]
- BOND RX™ Validated
- 20ul selling size
- Recombinant
- Advanced Validation
- RabMAb
- What is this?
Be the first to review this product! Submit a review
|
(13 Publications)
Rabbit Recombinant Monoclonal Loricrin antibody. Suitable for mIHC, IHC-P, WB and reacts with Human samples. Cited in 13 publications.
View Alternative Names
LOR, LRN, LORICRIN, Loricrin
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Loricrin antibody [EPR7148(2)(B)] (AB176322)
Immunohistochemical analysis of paraffin-embedded Human skin tissue labeling Loricrin using ab176322 at a 1/250 dilution.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- mIHC
Supplier Data
Multiplex immunohistochemistry - Anti-Loricrin antibody [EPR7148(2)(B)] (AB176322)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human skin tissue labelling Aquaporin 3 with ab307969 at 1/5000 dilution (0.094 µg/mL) (B), Loricrin with ab176322 at 1/3000 dilution (0.031 μg/ml) (C) and Filaggrin with ab221155 at 1/2000 dilution (0.523 μg/ml) (D). Opal Polymer HRP Ms + Rb was used as a secondary antibody, and DAPI was used for a nuclear counter stain. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins. Panel A : merged staining of anti-Aquaporin 3 (magenta; Opal™690), anti-Loricrin (green; Opal™520) and anti-Filaggrin (red; Opal™570) on human skin. Panel B : anti-Aquaporin 3 stained on keratinocytes from the stratum basale to the stratum granulosum of the epidermis. Panel C : anti-Loricrin stained on stratum corneum. Panel D : anti-Filaggrin stained on the granular to stratum corneum transition. The section was incubated in three rounds of staining : in the order of ab307969, ab176322, and ab221155 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system. The immunostaining was performed on a Leica Biosystems BOND® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.
- WB
Supplier Data
Western blot - Anti-Loricrin antibody [EPR7148(2)(B)] (AB176322)
All lanes:
Western blot - Anti-Loricrin antibody [EPR7148(2)(B)] (ab176322) at 1/10000 dilution
All lanes:
Human skin lysate at 10 µg
Predicted band size: 26 kDa
false
Related conjugates and formulations (8)
-
Anti-Loricrin antibody [EPR7148(2)(B)] - BSA and Azide free
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-Loricrin antibody [EPR7148(2)(B)]
-
578 PE
PE Anti-Loricrin antibody [EPR7148(2)(B)]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-Loricrin antibody [EPR7148(2)(B)]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Loricrin antibody [EPR7148(2)(B)]
-
660 APC
APC Anti-Loricrin antibody [EPR7148(2)(B)]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Loricrin antibody [EPR7148(2)(B)]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-Loricrin antibody [EPR7148(2)(B)]
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Publications (13)
Recent publications for all applications. Explore the full list and refine your search
Clinical, cosmetic and investigational dermatology 18:1151-1162 PubMed40356846
2025
Applications
Unspecified application
Species
Unspecified reactive species
Aging cell 24:e70024 PubMed40241256
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of the European Academy of Dermatology and Venereology : JEADV 37:605-614 PubMed36367625
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 23: PubMed36361668
2022
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of investigative dermatology 142:1670-1681.e12 PubMed34740582
2021
Applications
Unspecified application
Species
Unspecified reactive species
Inflammation 44:2006-2017 PubMed34037897
2021
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of investigative dermatology 141:2178-2188.e6 PubMed33984347
2021
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 11:7070 PubMed33782484
2021
Applications
Unspecified application
Species
Unspecified reactive species
Experimental dermatology 30:792-803 PubMed33455013
2021
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of investigative dermatology 140:1556-1565.e11 PubMed31987884
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com